We use cookies to make this site work. We'd also like to set optional cookies so we can understand how the site is used and improve it. We will not set optional cookies unless you accept them. You can change your choice at any time from the Cookie settings link in the footer.
Strictly necessary cookies
These cookies are required for the site to work. They store your cookie preferences and keep your session secure. They are exempt from consent under PECR Regulation 6(4) because they are essential to deliver the service you have requested.
Optional cookies
Optional cookies help us understand how the site is used and provide additional features such as analytics, accessibility tools and translation. We will only set them if you accept.
Research
We are a Research Ready accredited practice.
At Nightingale Valley Practice, we are committed to providing the highest quality care for our patients, and research plays a vital role in helping us achieve this. Participating in medical research allows us to stay at the forefront of advancements in healthcare, ensuring that the treatments and services we offer are safe, effective, and tailored to the needs of our community.
We warmly invite all our patients to get involved in research. Your participation, whether through clinical studies, surveys, or patient feedback initiatives, helps us gain valuable insights that can improve care not only for you but for future generations. Engaging in research is a unique opportunity to contribute to the development of new treatments, better understand health conditions, and shape the future of general practice.
Joining research studies is entirely voluntary, and we encourage patients to explore opportunities at a pace that suits them. Whether you are curious about participating in ongoing studies or simply want to learn more about the research we conduct, your involvement makes a real difference.
Together, we can advance healthcare, strengthen our community, and ensure that the voice of every patient is hard in the development of innovative medical care.
The research team consists of:
- Dr Katharine Alsop - Lead GP for Research
- Olive Wood - Research/Advanced Nurse Practitioner
- Jessie Hawkes - Administration Research Lead
Research Studies
CORAL
CORAL stands for COenzyme Q10 in heaRt fAiLure and is a clinical trial run by the Bristol Trials Centre at the University of Bristol.
Heart failure is a long-term condition that causes difficulty breathing, tiredness and leg swelling, which can all impact daily life. Between 10 and 15% of people over the age of 75 have heart failure and it is responsible for around 5% of all emergency hospital admissions. Most people with heart failure have two or more long-term medical conditions and usually take several different medicines every day.
Duration
Impact of duration of antibiotic therapy on effectiveness, safety and selection of antibiotic resistance in adult women with urinary tract infections (UTI): a randomised controlled trial.
Our main goal is to find to find the shortest antibiotic treatment duration needed to effectively treat urinary tract infections (UTIs) in women. We will measure this by seeing how many study participants stay healthy without needing more medical help for their utis up to 42 days after treatment.
IID3
The Third Infectious Intestinal Disease Study
In brief, the IID3 study design comprises three population-based studies: two prospective studies in Primary Care, and a microbiology study involving diagnostic and reference microbiology and AMR determination.
The research aims to address the question of whether the incidence of infectious intestinal disease (IID) in the community changed since the late 2000s.
INDIGO Community
Investigating Digital Outcomes in a community setting for patients living with and beyond a diagnosis of cancer. To understand more about the long-term outcomes and service use of patients living with and beyond a diagnosis of cancer. Phase II randomized feasibility research administering questionnaires in a mixed methods study.
Stabilise
The aim of this study is to provide an initial evaluation of a psychological therapy designed to address these ongoing symptoms. A total of 60 people (across two sites: Devon and Avon &Wiltshire NHS Trust) will be randomly allocated on a 1:1 ratio to receive either a novel psychological intervention for inter-episode bipolar symptoms plus usual care, or usual care only.
Year-round virology swabs
Virology swabs are used to collect samples for the detection and identification of viruses, particularly respiratory viruses like influenza and COVID-19. They are crucial for virology surveillance, helping to track viral spread, assess vaccination effectiveness, and inform public health decisions.
These swabs must be within 10 days of symptom onset.
TRANSFORM
We are helping identify people registered with us to take part in a large study called TRANSFORM. TRANSFORM is being run by Imperial College London and funded by Prostate Cancer UK and the UK government’s National Institute for Health and Care Research (NIHR).
What is TRANSFORM?
TRANSFORM is a study that will try to find the best way to detect prostate cancer early. The study will help the NHS decide whether a national screening programme for prostate cancer should be introduced in the future.
Who could be invited?
Invitation letters are being sent to selected men aged 45 to 74. If you are invited, you will receive more details about the study and can decide if you would like to take part. The invitation will come from your GP practice on behalf of Imperial College London. If you choose to take part, you will be asked to give your consent.
Whose health records will be used?
The study will also use information from NHS records for some men who:
- have not been invited
- are eligible, but do not respond
This information is used in a secure and confidential way. The information will provide valuable evidence for the study. You do not need to do anything unless you wish to opt- out.
Don’t want your data used in TRANSFORM?
If you don’t want your health information to be used for TRANSFORM, you can opt-out at any time. Opting out will not affect your NHS care or your ability to take part in other screening programmes or studies in the future. To opt-out, please contact the TRANSFORM study team directly by email, phone or post:
- Email: imperial.transformstudy@nhs.net
- Phone: 020 7594 6002
- Post: TRANSFORM Study Team, Imperial Clinical Trials Unit, 1st Floor, Stadium House, 68 Wood Lane, London W12 7RH